Sponsor Deadline
Posted: 3/2/2022

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research – U.S.

Pfizer  Global  Medical  Grants  (GMG)  supports  the  global  healthcare  community’s  independent initiatives  (e.g.,  research,  quality  improvement,  or  education)  to improve patient  outcomes  in areas  of unmet  medical  need  that  are  aligned  with  Pfizer’s  medical  and/or  scientific  strategies. Pfizer’s GMG  competitive grant  program  involves  a publicly  posted  general  Request  for  Proposal (RFP)  that  provides  detail  regarding a  general  area of  interest,  sets  timelines  for  review  and approval, and  uses  an internal  Pfizer  review  process  to make final  grant  decisions.  Organizations  are invited to submit  an  application  addressing  the  research  gaps  as  outlined  in  the  specific  RFP. 

Research projects that will be considered for support include:  

• Early identification, evaluation, diagnosis, prognosis & treatment

 • Natural history  

• Epidemiology o Prevalence of TTR amyloidosis among at-risk populations (e.g. carpal tunnel syndrome, aortic stenosis, hypertrophic cardiomyopathy, lumbar spinal stenosis, hip & knee arthroplasty, atrial fibrillation)  o Changing epidemiology of cardiac amyloid subtypes (hereditary vs wild-type)  

• Scintigraphy  o Use of scintigraphy for diagnosis of early disease and/or monitoring disease progression  o Phenotype and management of patients with Perugini Grade 1 uptake

 • New methodology to accelerate appropriate ATTR CM patient identification including Machine learning/ Artificial Intelligence and new biomarkers

• Study of hereditary ATTR genotypes and phenotypes o Non-Val30Met genotypes  o Val122Ile, Thr60Ala, Val30Met, and others

 • Mixed phenotypic manifestations (e.g. polyneuropathy and cardiomyopathy)  

• Use of tafamidis in the clinical setting (i.e. real world evidence) 

Grant Application due date: May 5, 2022

Eligibility Requirements

Geographic Scope: United States 

• The institution and principal investigator (PI) must be based in one of the eligible countries noted above. • Only organizations are eligible to receive grants, not individuals or medical practice groups. • The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work. • Applicant must be affiliated with a host institution 

Amount Description

Individual projects requesting up to $75,000 will be considered.

Amount
$75,000
Funding Type
Eligibility
Posted
3/2/2022
Deadline
Sponsor: